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19th CardioVascular Summit: TCTAP 2014MASD) especially when two or more occluders should be used, then the procedure
involves more clinical experience and high incidence of complication. Since 1998, 17
patients with MASD have been treated with two occluders in our hospital, this article
is to evaluate the clinical feasibility and effectiveness of transcatheter closure of
MASD using two occluders.
Methods: 17 patients underwent transcatheter closure of MASD(2 or 3) with two
devices under X-ray ﬂuoroscopy and TTE. Electrocardiogram, X-ray chest radiog-
raphy as well as echocardiography were performed to evaluate the effectiveness after
the procedure.
Results: All patients had MASD (12 with 2 defects and 5 with 3 defects). TTE during
the procedures showed that the mean diameters of the larger, medium and smaller
defects was (13.943.21)mm, (9.652.64)mm and (4.801.92)mm, respectively.
Transcatheter closure of MASD succeeded in 16 patients (16/17,94.12%),1 failed
because the second defect was not suitable for intervention, and was cured by surgery.
Totally 32 occluder devices were implanted with 37 defects closed. The mean di-
ameters of the larger and the smaller occluders was (20.754.07)mm and
(16.943.75)mm, respectively, larger than the value showed by TTE during pro-
cedures by (7.062.65)mm (larger defects) and (7.443.25)mm (medium defects).
Immediately after the procedure, 3 patients had trivial shunt (2 patients with 3 defects),
which disappeared 2days, 3 days and 3 month later, respectively. No severe
complication occurred, while femoral arteriovenous ﬁstula was observed in 1 patient
and disappeared 1 month later. The cardiothoracic ratio of X-ray chest radiography
and the right ventricle internal diameter measured by echocardiography dropped
during follow-up (all P<0.01).
Conclusion: Transcatheter closure of MASD with two devices is feasible, safe and
effective.
TCTAP A-056
Beneﬁts of Percutaneous Atrial Septal Defect Occlusion in Patients Older than 60
Yam Hong Wong
Tuen Mun Hospital, Hong Kong, Hong Kong, China
Background: Excellent beneﬁts of percutaneous transcatheter secundum atrial septal
defect (ASD) occlusion at young age have been well demonstrated. Evidence
demonstrating that in elderly patient is not well established. In fact, early investigators
demonstrated less favourable results when closure is delayed until late adulthood. A
few recent studies, including the one published by Humenberer M et al in 2011,
supported that beneﬁts are still present after ASD occlusion in elderlies, but possibly
to a smaller magnitude. Most of these evidence supporting closure of ASD in older
population are relatively small-scale, or single-centered studies. Post-operative new
onset atrial arrhythmias were also shown to be more common in geriatric population.
Furthermore, latest evidence suggested an increased incidence of post-operative heart
failure, due to diastolic dysfunction in this age group.
It is crucial, to conﬁrm the signiﬁcance and magnitude of beneﬁts, and also the
safety proﬁle of ASD repair in geriatric patients, in order to justify this treatment.
Methods: With an “all-comers” design, all adult patients with percutaneous ASD
occlusions ever performed in the involved tertiary cardiac centers in Hong Kong were
recruited. They were divided into the younger (< 60 years) and older ( 60 years) age
groups. Pre-operative and earliest post-operative measurements of pulmonary arterial
systolic pressure (PASP), and right ventricular internal diastolic diameter (RVID) were
assessed as primary endpoints. Subjective symptoms, incidence of new onset atrial
arrhythmia, thromboembolism, and bleeding complications were recorded as second-
ary endpoints. These results in the two age groups were then compared with each other.
Results: 54 younger and 19 older patients were evaluated. Highly signiﬁcant im-
provements pulmonary hypertension in terms of PASP (from 42.09  11.37 mmHg to
31.93  9.71 mmHg in the younger; and from 52.40  17.01 mmHg to 36.81  12.11
mmHg in the older age group) (Figure 1 and 2), and right ventricle (RV) dilation in
terms of RVID (from 3.54  0.86 cm to 2.67  0.66 cm in the younger; and from
3.85  0.68 cm to 3.02  0.71 cm in the older age group) (Figure 3 and 4) were noted
in both groups of patients.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORAAbsolute changes in PASP and RVID did not signiﬁcantly differ amongst age
groups (Figure 5 and 6).All secondary endpoints, including safety outcomes, are also statistically similar
between the older and the young age groups. Complications are rare. And majority of
symptomatic patients in both groups experienced symptom improvements after the
procedure (Figure 7).L/Congenital Heart Disease S17
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19th CardioVascular Summit: TCTAP 2014Conclusion: To our best knowledge, this was the ﬁrst multi-centered in this ﬁeld, and
also the ﬁrst study of its kind in the locality. Expanding the existing body of evidence,
this retrospective observational study demonstrated that echocardiographic and clin-
ical improvements after ASD occlusion are signiﬁcant even if it is done after the age
of 60. These improvements on pulmonary hypertension, RV dilation, and subjective
symptoms were achieved to a similar magnitude in both age groups. The procedure
can be safely performed in these geriatric patients and the incidences of complications
such as new onset atrial arrhythmias were not different from the younger age group.
Thromboembolism or bleeding complications are rare, and were not recorded in the
older age group in this study. ASD occlusion should therefore be recommended to
eligible patients, even after the age of 60.
TCTAP A-057
The Predictors of Atrial Septal Defect Occluder Dislodgement - A Comparative
Study Between Adult and Children
Hsiu-Yu Fang
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Background: Percutaneous device closure for atrial septal defects (ASDs) has
emerged as an alternative to traditional surgical closure. There are still many concerns
about the adverse events during procedure such as ASD occluder dislodgement.
However, information about the predictors of ASD occluder dislodgement remained
limited. The objective was to determine the predictors for ASD occluder dislodgement
for adult and children patients in our hospital.
Methods: From June 2003 to June 2013, 115 adults and 98 children patients were
diagnosed with ASD and offered transcatheter closure of their defects using atrial
septal occluder (ASO). The ASO was implanted under transesophageal echocardi-
ography (TEE) guidance.
Results: The ASO dislodgement rate was 4.7% (10/213). In the population of
dislodgement, seven cases were adult and three were children. The patient was then
referred to surgery if ASO dislodged. The thicker the least thickness of any rim was,
the more the ASO dislodged (p<0.005). The least rim thickness of 3 1.88mm had the
best sensitivity and speciﬁcity using receiver operating characteristic (ROC) curve
analysis (p¼0.026). The correction of the least thickness of any rim by body surface
area (BSA) was also found to present statistical signiﬁcance in adults and children.
The results of multivariate analysis demonstrated that high QP/QS, ﬂoppy or erosion
rim post-implantation and the least rim thickness were independent predictors for ASO
dislodgement (p<0.05).
Conclusion: Percutaneous device closure of atrial septal defects (ASDs) is safe and
effective at current era. Qp/Qs, the least rim thickness and ﬂoppy and erosion of the
rim could predict ASO dislodgement.
TCTAP A-058
Stent Fenestration of the Atrial Septum in Patients with Idiopathic Pulmonary
Hypertension
Bagrat Alekyan, Manolis Pursanov, Sergey Gorbachevskiy, Anasthasia Tkacheva,
Yuriy Kolcov, Gulam Dadabaev
Bakuolev Center for Cardiovascular Surgery, Moscow, Russia
Background: Pulmonary arterial hypertension is characterized by a progressive in-
crease of pulmonary vascular resistance and ultimately leads to the development of
right ventricular failure. Natural course of the idiopathic pulmonary hypertension is
malignant, and from the moment of establishing the diagnosis, without administering
speciﬁc drug therapy, is less than 3 years. It is proved that the presence of the foramen
ovale in patients with primary pulmonary hypertension improves the prognosis of the
disease and increases the life span.
Methods: 42 patients with primary pulmonary hypertension underwent transcatheter
creation of the interatrial septum fenestration through stenting in The Bakoulev Sci-
entiﬁc Center for Cardiovascular Surgery (Bakoulev CCVS). The age of the patients
ranged from 5 to 44 years (average 16.2  7.8). 20 patients had III heart failure
functional class, 22 patients had IV functional class. The systolic pressure in the
pulmonary artery ranged from 80 to 188 mmHg (average 105  45), in the right
atrium - from 10 to 18 (average 15  2) while the oxygen saturation of the arterial
blood ranged from 88% to 94% (average 90  2%). All interventions were performed
under general anesthesia and transesophageal echocardiographic control. In 28 cases
hourglass-type stenting of the interatrial septum fenestration (ISF) was performed with
the Palmaz Balloon-Expandable Stents of 27.0 and 36.0 length. In 12 cases stenting
without modiﬁcation of the stent was performed with 6-7 mm diameter and 3-4 cm
length peripheral stents.
Results: In 95.3% of cases interventions and creation of the ISF from 5.0 to 8.0 mm in
diameter were successfully performed. ISFs were created with the diameter of 5.0 mm
in 15 patients, of 6.0 mm - in 21 patients, and of 8.0 mm - in 4 patients. Increase in the
pulmonary artery systolic pressure on the average from 105  45 to 125  40 with a
slight decrease in oxygen saturation of the arterial blood (90  2 to 89  2%) was
observed in all patients immediately after the intervention.
In a long-term period 33 patients were examined within the period from 5 months to
8 years (average 31.3  14.2 months). Improvement in the clinical condition and
quality of life of the patients is observed in most cases. Thus, 17 patients were
reclassiﬁed to II functional class, 11 patients - to III functional class, and 2 patients - to
IV functional class. At the same time an increase from 163  54 to 294  38 m
is observed according to the 6-minute walk test results. Long-term mortality was 9.1%
(n ¼ 3).S18 JACC Vol 63/12/Suppl S j AConclusion: Stent fenestration of the interatrial septum in patients with idiopathic
pulmonary arterial hypertension improves the quality of life of patients, besides, it
allows increasing the patient’s life span, and it can be a bridge to lung or heart-lung
transplantation.
TCTAP A-059
Plasma Level of Secretory Type Ii Phospholipase A2 Is Pathophysiologically
Associated with Pulmonary Artery Pressure in Congenital Atrial Septum Defect
Subjects
Ping-Yen Liu, Jeihneng Wang, Jing-Min Wu
National Cheng Kung University Hospital, Tainan, China
Background: Patients with an atrial septum defect (ASD) tend to develop progressive
pulmonary arterial hypertension (PAH). Recent studies showed that a secretory
phospholipase A2 (sPLA2) inhibitor could rescue PAH by acting on ion channel ac-
tivity. We aimed to survey the changes of sPLA2 and its association with PAH after
the percutaneous closure device intervention on ASD patients.
Methods: Patients with diagnosis of ASD and admitted to our hospital for the pro-
cedure of ASD occluder procedure were consecutively enrolled in our study. He-
modynamic parameters, novel biomarkers, including sPLA2, and echocardiographic
studies were performed before and after implantation of the closure device for ASD.
PAH was measured both from catheterization monitor and echocardiographic
measurement.
Results: Forty-two ASD (88.1% female) patients, mean age of 40.7  18.5 years,
were enrolled in this study and compared with another sex-age- matched control
group (n¼40). The mean PA pressure of ASD patients was 35.1  7.6 (16 to 81)
mmHg. Compared with the control subjects, ASD patients had higher level of
sPLA2 (274  44 vs. 172  13 ng/dl, p<0.01). The age, ASD size, and PA
pressure were all positively correlated with sPLA2 level (all p<0.05); with PA
pressure had the most signiﬁcant correlation. ASD patients with PAH had higher
sPLA2 than those without (298  32 vs. 230  22 ng/dl, p<0.02). After ASD
occlude procedure, the level of sPLA2 decreased signiﬁcantly among those with
baseline PAH subgroup (D¼-120  22 ng/dl, p<0.01), but not without PAH
subgroup (D¼-43  20 ng/dl, p¼0.09). However, the sPLA2 levels were similar in
both groups after procedure (p¼0.42). Furthermore, the change of sPLA2 was also
strongly associated with the decreased level of PAH after procedure (R¼0.45,
p¼0.002).
Conclusion: Our results support the ﬁndings that sPLA2 is crucial in PAH under ASD
condition and has a both therapeutic and pathophysiologic role for further treatment
strategy.
TCTAP A-060
Simultaneous Endovascular Correction of ASD and Coronary Lesions in Adults
with Congenital and Coronary Heart Diseases
David G. Iosseliani, Ilya Kovalchuk, Vladislav Kriukov, Irina Kibizova,
Alexander Stepanov, Pavel Vasiliev
City Center of Intervent.Cardioangiology, Moscow, Russian Federation
Background: ASD secundum in adults is often associated with coronary heart
disease. Meanwhile there is no commonly adopted tactics for the treatment of such
patients: should it be simultaneous or staged?
Methods: 55 patients underwent endovascular ASD closure, in 5 of them (8,6%) this
procedure was combined with simultaneous coronary stenting. The average age of
these patients was 63,2  7,0 years. Two patients had history of MI. All patients had
clinical signs of coronary heart disease and heart defect (including migraine-like
pain in 2 cases). Average SYNTAX score was 11,9  6,3. The average number
of implanted stents per patient was 2,0  1,0. The average time of ﬂuoroscopy was
19,4  9,5 min, the average volume of contrast medium used– 205,8  65,9 Ml. The
average size of ASD assessed by TEE was 12,8  2,9 mm.
Results: At ﬁrst we performed coronary stenting followed by ASD closure with an
occluder. Technical success rate was 100%. Five ASD occluders (mean diameter
21,88,1 mm) were implanted in 5 patients. Complete ASD closure immediately after
occulder implantation was noted in 5 (100%) cases. Coronary stenting was performed
in all cases, in 2 patients – after successful recanalization of chronic occlusion. Early
postoperative period was uneventful. At control examination (average - 13,5  1,5
months) complete defect closure persisted in all patients. At TEE, the RA volume
decreased from 48,6  5,6 to 32,6  3,8 cm3 (p<0,01), the RV volume – from 43 
6,1 to 32,4  4,8 cm3 (p<0,01), mean PAP decreased from 45,4  11,3 to 25,6  6,8
mm Hg (p<0,01). Preoperative symptoms disappeared in all 5 patients. Control CAG
conﬁrmed persisting effect of PCI. According to exercise testing, physical tolerance
increased from 68,5  11,8 to 85,3  12,4 Wt.
Conclusion: Simultaneous combined endovascular ASD closure and coronary stent-
ing in adults is quite safe and effective and provides greater comfort for the patients by
reducing their hospital stay. The performance of these procedures did not lead neither
to signiﬁcant increase of contrast medium expenditure, nor to the increase of patients.pril 22–25, 2014 j TCTAP Abstracts/ORAL/Congenital Heart Disease
